India’s Shilpa Medicare To Make Cadila’s COVID-19 Vaccine
Indian drugmaker Shilpa Medicare Limited had agreed to produce Cadila Healthcare Ltd’s three-dose COVID-19 vaccine, it said on Friday. The emergency approval has been given to the country’s health authorities…
Share